The comparative release of FGF1 by hypoxia and temperature stress

Growth Factors

Volumn 18, Issue 4, 2001, Pages 277-285

  Mouta Carreira, C ^a   Landriscina, M ^a   Bellum, S ^a   Prudovsky, I ^a   Maciag, T ^a  

^a Maine Medical Center Research Institute   (United States)

Author keywords

Fibroblast growth factor; Hypoxia; Phospholipids; Synaptotagmin

Indexed keywords

ARACHIDONIC ACID; CYSTEINE; FIBROBLAST GROWTH FACTOR 1; LIPOXYGENASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN P40; SYNAPTOTAGMIN;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL CULTURE; CELL HYPOXIA; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; STRESS; TEMPERATURE;

ANIMALIA;

EID: 0034893874     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.3109/08977190109029116     Document Type: Article

References (33)

1. Oxidized LDL mediates the release of fibroblast growth factor-1
2. The heparin-binding (fibroblast) growth factor family of proteins
3. S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro
4. ECV304 (endothelial) is really T24 (bladder carcinoma): Cell line cross-contamination at source
5. S-100 proteins: Relationships with membranes and the cytoskeleton
6. Differential transforming abilities of non-secreted forms of human fibroblast growth factor-1
7. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
8. Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling
9. Tumor induction of VEGF promoter activity in stromal cells
10. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells
11. The release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues
12. FGF-1 but not FGF-4 secreted by carcinoma cells promotes in vitro and in vivo angiogenesis and rapid tumor proliferation
13. FGF-FGFR signaling in vertebrate organogenesis
14. Signal transduction by fibroblast growth factor receptors
15. Amlexanox reversibly inhibits cell migration and proliferation and induces the Src-dependent disassembly of actin stress fibers in vitro
16. Synaptotagmin-1 is required for fibroblast growth factor-1 release
17. Overexpression of protein kinase C-zeta isoform increases cyclooxygenase-2 and inducible nitric oxide synthase
18. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo
19. Multiple targets for brefeldin A
20. Regulation of eye derived growth factor binding to membranes by light, ATP or GTP in photo-receptor outer segments
21. Extracellular FGF-1 acts as a lens differentiation factor in transgenic mice
22. The antiallergic agent amoxanox suppresses SRS-A generation by inhibiting lipoxygenase
23. Synaptotagmins: More isoforms than functions?
24. A carboxyl-terminal domain in fibroblast growth factor (FGF)-2 inhibits FGF-1 release in response to heat shock in vitro
25. Serum-starvation induces the extracellular appearance of FGF-1
26. Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family
27. The cysteine residue responsible for the release of fibroblast growth factor-1 resides in a domain independent of the domain for phosphatidylserine binding
28. The extravesicular domain of synaptotagmin-1 is released with the latent fibroblast growth factor-1 homodimer in response to heat shock
29. Effects of antioxidants on cyclooxygenase and lipoxygenase activities in intact human platelets: Comparison with indomethacin and ETYA
30. Regulation of cyclooxygenases by protein kinase C. Evidence against the importance of direct enzyme phosphorylation
31. Immediate responses of endothelial cells to hypoxia and reoxygenation: An in vitro model of cellular dysfunction
32. Characterization of the human and mouse cDNAs coding for S100A13, a new member of the S100 protein family
33. Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: Reversal by suramin